Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
James Healy is Managing Partner at Sofinnova, where he has spent more than two decades investing in biotechnology and companies developing transformative therapies. Sofinnova’s investors are active across Seed and Series A, with published ranges including $100K - $5.0M. Before joining Sofinnova in 2000, Healy held roles at Sanderling Ventures, Bayer Healthcare Pharmaceuticals, and ISTA Pharmaceuticals.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.